Literature DB >> 16934888

Hypothesis: VPAC G protein-coupled receptors for vasoactive intestinal peptide constitute a dynamic system for signaling T cells from plasma membrane and nuclear membrane complexes.

Edward J Goetzl1.   

Abstract

The vasoactive intestinal peptide (VIP)-VPAC(1) and VPAC(2) G protein-coupled receptor (GPCR) systems are autocrine and paracrine regulators of diverse T cell functions. It has been recognized that VIP evokes two types of T cell responses. The first are rapid in onset and brief in duration, such as altered traffic in blood, lymphoid corridors, and tissues. The second are slow in onset and sustained in duration, such as enhanced helper T cell (Th) differentiation in the thymus and increased survival in lymphoid tissues with biases favoring the Th2-type effector and memory subsets. Investigations of some other sets of GPCRs for peptide and lipid mediators have demonstrated expression both in nuclear membranes and plasma membranes with respective linkages to responses that are slow in onset and sustained, and those that are rapid in onset and brief in duration. The hypothesis presented in this paper suggests that plasma membrane VPAC receptors transduce short-term effects of exogenous VIP on T cell effector functions, whereas nuclear VPAC receptors mediate endogenous VIP alterations in differentiation, proliferation, and survival. The types of substantial additional proof needed to support this hypothesis are described, as are its advantages for more selective VIP-directed therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934888     DOI: 10.1016/j.regpep.2006.04.022

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  6 in total

Review 1.  Perspective is everything: an irreverent discussion of CNS-immune system interactions as viewed from different scientific traditions.

Authors:  Monica J Carson; David D Lo
Journal:  Brain Behav Immun       Date:  2007-01-17       Impact factor: 7.217

2.  The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation.

Authors:  Chaneun Nam; Adam J Case; Bruce S Hostager; M Sue O'Dorisio
Journal:  J Mol Neurosci       Date:  2008-07-29       Impact factor: 3.444

3.  Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients.

Authors:  R Villanueva-Romero; I Gutiérrez-Cañas; M Carrión; I González-Álvaro; J M Rodríguez-Frade; M Mellado; C Martínez; R P Gomariz; Y Juarranz
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.379

Review 4.  An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance.

Authors:  Rosa P Gomariz; Yasmina Juarranz; Mar Carrión; Selene Pérez-García; Raúl Villanueva-Romero; Isidoro González-Álvaro; Irene Gutiérrez-Cañas; Amalia Lamana; Carmen Martínez
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-22       Impact factor: 5.555

5.  Human CD4+CD45RA+ T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide.

Authors:  Raúl Villanueva-Romero; Alicia Cabrera-Martín; Emigdio Álvarez-Corrales; Mar Carrión; Selene Pérez-García; Amalia Lamana; David Castro-Vázquez; Carmen Martínez; Rosa P Gomariz; Irene Gutiérrez-Cañas; Yasmina Juarranz
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

6.  Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.

Authors:  Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Fernanda Bernardi Bertonha; Filipi Nascimento Silva; Luciano da Fontoura Costa; Leandro Rodrigues Ferreira; Glaucio Furlanetto; Paulo Chacur; Maria Claudia Nogueira Zerbini; Magda Carneiro-Sampaio
Journal:  Oncotarget       Date:  2016-02-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.